HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic

See also
Status	Clinical Trial	Phase
Completed	`NCT03314857` - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population	N/A
Completed	`NCT03666351` - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease	Phase 4
Recruiting	`NCT06034028` - J-Valve TF Early Feasibility Study	N/A
Completed	`NCT05515848` - Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Active, not recruiting	`NCT03549091` - Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI	N/A
Completed	`NCT01598844` - JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
Active, not recruiting	`NCT03466918` - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population	N/A
Active, not recruiting	`NCT04415047` - The JenaValve ALIGN-AR Pivotal Trial	N/A
Not yet recruiting	`NCT05319171` - Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.
Completed	`NCT05774795` - LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
Terminated	`NCT02351726` - Mitroflow DL Post Approval Study- North America	N/A
Completed	`NCT00624884` - Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation	N/A
Recruiting	`NCT04038879` - Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Completed	`NCT05332184` - Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Completed	`NCT01400841` - HAART Model 300 Annuloplasty Ring	N/A
Not yet recruiting	`NCT02633423` - Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery	N/A
Completed	`NCT00976625` - Diastolic Dysfunction in Aortic Regurgitation	N/A
Enrolling by invitation	`NCT05714293` - CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.	N/A
Recruiting	`NCT02974920` - Rivaroxaban or Aspirin for Biological Aortic Prosthesis	Phase 4
Not yet recruiting	`NCT03788590` - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System	N/A

NCT number	NCT05409378
Study type	Interventional
Source	HLT Inc.
Contact
Status	Withdrawn
Phase	N/A
Start date	July 8, 2022
Completion date	January 20, 2023

HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation — RIVAL - AR EFS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms